TODESCHINI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 5.099
NA - Nord America 4.678
AS - Asia 2.692
SA - Sud America 365
AF - Africa 34
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.888
Nazione #
US - Stati Uniti d'America 4.637
RU - Federazione Russa 1.564
GB - Regno Unito 1.309
SG - Singapore 1.193
CN - Cina 902
DE - Germania 456
IT - Italia 416
SE - Svezia 373
FR - Francia 324
BR - Brasile 311
FI - Finlandia 226
IE - Irlanda 219
HK - Hong Kong 218
VN - Vietnam 113
UA - Ucraina 88
KR - Corea 67
IN - India 35
TR - Turchia 29
BE - Belgio 28
AR - Argentina 27
CA - Canada 22
NL - Olanda 20
ID - Indonesia 19
JP - Giappone 19
IR - Iran 17
PL - Polonia 16
BD - Bangladesh 15
ES - Italia 13
AU - Australia 10
EG - Egitto 9
IQ - Iraq 9
RO - Romania 9
MX - Messico 8
PK - Pakistan 8
UZ - Uzbekistan 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CO - Colombia 6
EU - Europa 6
LT - Lituania 6
AL - Albania 5
CH - Svizzera 5
EC - Ecuador 5
PE - Perù 5
CZ - Repubblica Ceca 4
IL - Israele 4
JO - Giordania 4
MA - Marocco 4
NP - Nepal 4
SA - Arabia Saudita 4
VE - Venezuela 4
BG - Bulgaria 3
BY - Bielorussia 3
LK - Sri Lanka 3
PA - Panama 3
TN - Tunisia 3
AT - Austria 2
CI - Costa d'Avorio 2
CL - Cile 2
EE - Estonia 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 12.888
Città #
Southend 1.104
Jacksonville 735
Singapore 602
Chandler 566
Moscow 497
Woodbridge 415
Dallas 401
Ashburn 329
Houston 284
Ann Arbor 258
Dublin 219
Hong Kong 216
Wilmington 108
Beijing 102
The Dalles 92
Los Angeles 91
Nanjing 89
Lawrence 87
Princeton 87
Jinan 83
Buffalo 80
New York 70
Shenyang 66
Boardman 50
Sindelfingen 50
Verona 44
Changsha 40
Hebei 40
Helsinki 39
Ho Chi Minh City 38
Tianjin 38
Munich 34
São Paulo 33
Milan 32
Columbus 30
Falls Church 29
Brussels 28
Zhengzhou 28
Guangzhou 26
Hanoi 26
Philadelphia 24
Ningbo 23
Seattle 23
Taizhou 23
Haikou 22
Nanchang 22
Turku 21
Bologna 20
Fairfield 20
Council Bluffs 19
Rome 19
Hangzhou 17
Jiaxing 17
Santa Clara 17
Cambridge 16
Norwalk 16
Tokyo 16
Nürnberg 15
Auburn Hills 14
Lancaster 14
Taiyuan 14
Warsaw 14
Bloomsbury 13
San Jose 13
Frankfurt am Main 12
Jakarta 12
Stockholm 12
Belo Horizonte 11
Paris 10
Rio de Janeiro 10
Brooklyn 9
Fuzhou 9
Lanzhou 9
Toronto 9
Washington 9
Alexandria 8
Brasília 8
Denver 8
Düsseldorf 8
Redondo Beach 8
Kent 7
London 7
Meda 7
Tashkent 7
Ardabil 6
Leawood 6
Phoenix 6
Poplar 6
San Francisco 6
Asiago 5
Atlanta 5
Cape Town 5
Chicago 5
Cormano 5
Dhaka 5
Haiphong 5
Lima 5
Melbourne 5
Monte San Savino 5
Redwood City 5
Totale 7.883
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 428
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 420
Acute leukemia and pregnancy. Case report 216
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 210
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 208
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 203
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 202
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 197
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 196
Blastic OKT6-positive proliferation preceding malignant histiocytosis 194
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 183
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 183
Unusual case of solitary intraparenchymal brain plasmacytoma. 182
[Invasive pulmonary aspergillosis: possibility of radiologic diagnosis] 181
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 180
A case of Listeria murray/grayi bacteremia in a patient with advanced Hodgking's disease 179
Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies 176
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 176
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 175
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 173
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 172
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 170
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 168
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 168
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 166
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 166
Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature 166
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 granulocytopenic patients with hematological malignancies 164
About mediastinal large B-cell lymphoma and other lymphoma entities. 164
A comprehensive genetic classification of adult acute lymphoblastic leukemia:analysis of the GIMEMA 0496 protocol 162
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 162
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 154
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases 153
Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol 153
Nosocomial Candidemia in an Italian tertiary care hospital 152
Immunologic abnormalities in angioimmunoblastic lymphadenopathy 148
Antilymphocyte globulin, cyclosporine, prednisone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients 147
ALK+ lymphoma: clinico-pathological findings and outcome 147
Mycobacterial infections preceding hairy-cell leukemia diagnosis. Description of two cases 145
Candidemia in cancer patients: a prospective , multicenter, surveillance study by the Invasive Fungal Infection Group (IFIG)of of the European Organization for Research and Treatment of Cancer (E.O.R.T.C.) 145
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 143
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease 143
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH) 143
Gram-negative septicemia in patients with hematologic malignancies 142
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 142
Cryptococcus in patients with hematologic malignancies. A report from GIMENA-infection 141
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 140
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 137
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 137
Acute lymphoblastic leukemia occurring as second malignancy : report od the GIMEMA Archive of Adult Acute Leukemia 136
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 133
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia 131
Hyperchidam Verona897 Regimen Is Effective in Treatment of Advanced Peripheral T Cell Lymphoma (PTCL): The GITIL Experience in 33 Cases 130
[Hodgkin's disease: gastric relapse with pleuric fistula after 4-years' complete remission] 129
Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia 127
Fanconi's anaemia in adults: study of three families 126
Mieloma multiplo non secernente 126
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 123
Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years'experience of infection in GIMEMA centres. 122
Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature. 116
Peripheral T-cell lymphoma unspecified (PTCL-U): a new model from a retrospective multicentric clinical study 115
Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients 115
Nosocomial Candidemia in non-neutropenic patients at an Italian tertiary care hospital 114
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia 114
Primary mediastinal large B-cell lymphoma (PML-BCL):long term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B 113
Follow-up of superoxide production by phagocytes in whole blood of leukaemic patients during therapy 112
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications 110
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 110
Serum levels of soluble interleukin-2 receptor in Hodgkin's disease: relationship with clinical stage, tumor burden and treatment outcome. A longitudinal study 109
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 108
Treatment of Candidiasis: a perspective on recent advances and future challenges 106
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma 106
Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 Years experience of infection in GIMEMA centres. 105
Diffuse metabolic activation of reticuloendothelium on F-18 FDG PET imaging in a case of visceral leishmania 104
IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. 103
Rituximab-CHOP or two-weekly CHOP +G-CSF in aggressive lymphoma of the ederly ? 103
Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis 101
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897) 101
Pneumocystis Carinii pneumonia in patients with hematological diseases:10 years experience in GIMEMA centers 100
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis 99
Idarubicin in patients with diffuse large cell Lymphomas: a randomized trial comparing VACOP-B (A= doxorubicin) vs VICOP-B (I=Idarubicin) 98
Replay to the letter: About systemic lupus erythematosus and thrombotic thrombocytopenic purpura 96
Trattato di Medicina Interna 96
Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc 95
High dose Antracyclin induction in ALL 94
NK/T-cell lymphomas 'nasal type': an italian multicentric retrospective survey 92
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. 82
null 55
Totale 12.957
Categoria #
all - tutte 38.074
article - articoli 33.287
book - libri 0
conference - conferenze 4.108
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 679
Totale 76.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021556 0 0 0 0 0 120 26 83 102 13 158 54
2021/2022876 58 226 7 103 55 37 15 49 34 45 78 169
2022/20231.573 125 136 158 278 152 385 22 96 161 1 40 19
2023/2024674 35 72 54 103 98 92 26 45 7 15 76 51
2024/20251.898 123 127 74 334 158 93 68 84 243 80 141 373
2025/20263.259 375 342 324 707 1.201 310 0 0 0 0 0 0
Totale 12.957